Weight-loss drug tirzepatide (Mounjaro) is due to be rolled out to 1.6 million patients over the next 12 years under NHS plans submitted to the National Institute for Health and Care (NICE). With NICE ...
Weight-loss jabs such as Wegovy have sparked a ‘tidal wave’ of demand on NHS obesity clinics (REUTERS/Jim Vondruska/Illustration) Hundreds of doctors and experts have called on the health secretary ...
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone who meets ...
LONDON, Dec 23 (Reuters) - Eli Lilly's (LLY.N), opens new tab obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after the drugs ...
The NHS incurs an estimated £340 million in additional healthcare costs annually due to weight-related health problems in children – but it is not just obesity driving the costs. New research from the ...
On Monday, Novo Nordisk A/S NVO introduced its popular weight loss drug Wegovy (semaglutide injection) in the U.K., making it accessible through the National Health Service (NHS) weight management ...
We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback